Hemostatic Function and Coronary Artery Disease
- 9 March 1995
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (10), 677-678
- https://doi.org/10.1056/nejm199503093321011
Abstract
Until recently, our understanding of the role of hemostatic factors in coronary artery disease was based primarily on cross-sectional studies, epidemiologic observations, and cross-cultural comparisons. In the past several years, however, the information derived from prospective epidemiologic studies has expanded considerably. Simultaneously, cell and molecular biologic studies have revealed some of the mechanisms that regulate the plasma levels and biologic activity of hemostatic proteins.The first two reports from the Northwick Park Heart Study, published in 1980 and 1986,1,2 demonstrated strong, independent associations of base-line plasma fibrinogen concentrations and factor VII coagulant activity with the risk of subsequent coronary . . .Keywords
This publication has 14 references indexed in Scilit:
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.Circulation, 1993
- Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Fibrinogen level as a predictor of mortality in survivors of myocardial infarctionFibrinolysis, 1991
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980